Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin (P2)

NCT02984644 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.

NCT NCT02984644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02984644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin (P2)
Lead sponsor
The University of Texas Health Science Center at San Antonio
Phase
Phase 3
Overall status
Completed
Start date
September 6, 2017
Completion date
November 16, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type ii; diabetes